We are live on ! Find out more
FP

Financial Perspectives Portfolio holdings

AUM $411M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+26.27%
3 Year Est. Return
+87.83%
5 Year Est. Return
+95.64%
10 Year Est. Return
AUM
$205M
AUM Growth
-$1.81B
Cap. Flow
-$48.1B
Cap. Flow %
-23,431.68%
Top 10 Hldgs %
45.86%
Holding
668
New
43
Increased
1
Reduced
605
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Technology 14.98%
3 Consumer Discretionary 7.08%
4 Communication Services 4.08%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJNK icon
601
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$2.18K ﹤0.01%
+79
New +$2.16K
HYLB icon
602
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
$2.18K ﹤0.01%
+54
New +$2.16K
USHY icon
603
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
$2.17K ﹤0.01%
+52
New +$2.15K
SPYV icon
604
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
$2.11K ﹤0.01%
53
-1,961
-97% -$77.5K
NUVA
605
DELISTED
NuVasive, Inc.
NUVA
$2.1K ﹤0.01%
31
-2,001
-98% -$137K
FCX icon
606
Freeport-McMoran
FCX
$91.2B
$2.08K ﹤0.01%
56
-1,788
-97% -$69.7K
ICUI icon
607
ICU Medical
ICUI
$4.21B
$2.06K ﹤0.01%
10
-2,044
-100% -$420K
WAB icon
608
Wabtec
WAB
$49.4B
$2.06K ﹤0.01%
25
-1,954
-99% -$159K
MAT icon
609
Mattel
MAT
$4.42B
$2.01K ﹤0.01%
100
-1,892
-95% -$39.1K
KMI icon
610
Kinder Morgan
KMI
$70.5B
$1.95K ﹤0.01%
107
-1,672
-94% -$29.8K
BBU
611
DELISTED
Brookfield Business Partners
BBU
$1.85K ﹤0.01%
62
-2,442
-98% -$69K
ARDS
612
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$1.85K ﹤0.01%
250
-1,225
-83% -$7.65K
COUP
613
DELISTED
Coupa Software Incorporated
COUP
$1.83K ﹤0.01%
7
-1,774
-100% -$439K
POST icon
614
Post Holdings
POST
$4.21B
$1.74K ﹤0.01%
24
-2,561
-99% -$189K
PAM icon
615
Pampa Energía
PAM
$4.77B
$1.73K ﹤0.01%
114
-1,578
-93% -$23.9K
SRCL
616
DELISTED
Stericycle Inc
SRCL
$1.72K ﹤0.01%
24
-1,596
-99% -$117K
EOG icon
617
EOG Resources
EOG
$77.5B
$1.67K ﹤0.01%
20
-1,431
-99% -$113K
LCID icon
618
Lucid Motors
LCID
$3.17B
$1.64K ﹤0.01%
+6
New +$1.32K
SUPN icon
619
Supernus Pharmaceuticals
SUPN
$2.65B
$1.6K ﹤0.01%
52
-1,309
-96% -$40.1K
ABMD
620
DELISTED
Abiomed Inc
ABMD
$1.56K ﹤0.01%
5
-1,589
-100% -$487K
CMG icon
621
Chipotle Mexican Grill
CMG
$48.8B
$1.55K ﹤0.01%
50
-71,000
-100% -$2.03M
BUD icon
622
AB InBev
BUD
$166B
$1.53K ﹤0.01%
21
-1,313
-98% -$95.8K
HPE icon
623
Hewlett Packard
HPE
$62.4B
$1.47K ﹤0.01%
101
-1,489
-94% -$23.5K
CPHC icon
624
Canterbury Park Holding Corp
CPHC
$78.5M
$1.47K ﹤0.01%
100
-1,268
-93% -$17.9K
STE icon
625
Steris
STE
$22.5B
$1.47K ﹤0.01%
+7
New +$1.41K

Similar funds

Financial Perspectives's Q2 2021 Portfolio in Review

As of Q2 2021, Financial Perspectives held 668 positions worth $205M, down 90% from $2.01B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Financial Perspectives withdrew a net $48.1B in Q2 2021, closing 16 positions and reducing 605 holdings. Its most notable exit was Brookfield Infrastructure Partners, an estimated $4.13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Financial Perspectives opened a new position in Brookfield worth $484K.

  • Financial Perspectives's largest Q2 2021 buy was Brookfield: 17,616 shares worth $484K.
  • Financial Perspectives added most to InspireMD in Q2 2021, an estimated $2.19K increase.
  • Financial Perspectives's biggest Q2 2021 reduction was Amazon, cutting an estimated $10B.
  • Financial Perspectives fully exited Brookfield Infrastructure Partners in Q2 2021, selling an estimated $4.13M.
  • Financial Perspectives's ten largest holdings make up 46% of its $205M portfolio in Q2 2021.
  • Financial Perspectives opened 43 new positions and closed 16 in Q2 2021.
  • Financial Perspectives's portfolio value fell 90% quarter-over-quarter to $205M.

Based on Financial Perspectives's 13F filing for Q2 2021, filed 10 Jan 2024.